Clarifying Obligation To Report Drug Patent Agreements
On May 9, 2011, the Federal Trade Commission's Bureau of Competition notified Sanofi-Aventis U.S. LLC, Watson Pharmaceuticals Inc. and Synthon Holding BV that the companies' failure to inform the FTC and...To view the full article, register now.
Already a subscriber? Click here to view full article